Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Traumatic Brain Injury
NCT06914310Phase 3Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Mar 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of memantine in traumatic brain injury (TBI) (2 arms), sponsored by Mansoura University. Primary endpoint: Montreal Cognitive Assessment at 30 days. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
memantine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06914310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06914310.